Introduction {#sec1-1}
============

Nowadays, diabetes is frequently seen in society, its prevalence is about 382 million people around the world \[[@ref1]\]. Diabetes is characterized by insufficient secretion rate of insulin or lack of insulin activity \[[@ref2], [@ref3]\]. Diabetes is associated with different health problems including cardiovascular diseases, neuropathy, retinopathy, ulcers and amputations \[[@ref4], [@ref5]\]. Treatment of diabetes is a complex issue but some animal models were developed to understand the management as diabetes is a chronic condition \[[@ref6], [@ref7]\]. Over 30 years, alloxan, streptozotocin (STZ, 2-deoxy-2-(3-(methyl-3- nitrosoureido)-D-glucopyranose), high-fat diet-fed and nicotinamid are used for establishing experimental diabetes models of animal \[[@ref8]\].

Streptozotocin is still commonly used agent to induce diabetes in rats and mice \[[@ref9]-[@ref12]\]. STZ is produced by Streptomycetes sachromogenes and STZ causes to abnormal B-cell functions by imparing glucose oxidatation and decreasing insulin biosynthesis and secretion \[[@ref13], [@ref14]\]. Szkudelski stated that STZ dose range is larger than alloxan and other agents and only one dose is enough to induce diabetes \[[@ref15]\]. Decrease in plasma insulin levels in animal models after STZ application is used a sign for inducement of diabetes \[[@ref16]-[@ref18]\]. In spite of reporting significant differences in plasma insulin levels after STZ application, majority of the studies using STZ do not report practical importance or effect sizes of the differences. But there is a need to show practical importance for future decisions on dose and time of STZ application.

Based on this idea, the purpose of this study is to make a meta-analysis of the studies on the effect of STZ on plasma insulin levels in diabetic organisms.

Materials and Methods {#sec1-2}
=====================

In this study, meta-analysis approach was used to evaluate practical importance of the differences regarding plasma insulin levels of STZ-induced diabetic rats and mice. Meta-analysis is different from a review including summarizing existent literature, since meta-analysis involves statistically synthesizing results of different studies \[[@ref19], [@ref20]\]. For meta-analysis in this study, Cohen's d effect size values were calculated for 37 studies and mean effect size value was found for deciding about average effect size value as an indicator of mean practical importance of the differences in plasma insulin levels induced by STZ.

Selection of the Publications {#sec2-1}
-----------------------------

In selection process of the publications PubMed, Google Scholar, Proquest and National Theses Database System were searched by using key words "Plasma insulin levels, STZ, Rats". The time restriction for the publications was 2005-2015. In National Theses Database System no thesis was found about the keywords it might be related to system error while Proquest search showed 89 theses. However, one thesis was found appropriate. When Pubmed was searched 526 results were found. As the highest publication number, Google scholar search results gave 3960 publications.

After adding the publications to the pool, checking abstracts and content of the publications were conducted. Eventually it was determined that 37 studies reported change in plasma insulin levels of diabetic organisms and they reported 39 differences for effect size calculations across different doses of STZ. Descriptive knowledge about the publications is represented in [Table 1](#T1 T2){ref-type="table"}. The titles of them can be seen in appendix ([Table 3](#T3){ref-type="table"}).

###### 

Descriptions of the publications in this study

  Publication Date   Name of Journal or Institution                              Subject   STZ Amount in the Application   Time between STZ application and plasma insulin measurement
  ------------------ ----------------------------------------------------------- --------- ------------------------------- -------------------------------------------------------------
  2005               Biochemical and Biophysical Research Communications         Rats      65 mg/kg                        9 days
  2005               Pharmacological Research                                    Rats      50 mg/kg                        4 weeks
  2005               Journal of Ethnopharmacology                                Rats      65 mg/kg                        15 days
  2005               Journal of Biochemistry and Molecular Biology               Rats      50 mg/kg                        6 weeks
  2006               Clinical and Experimental Pharmacology and Physiology       Rats      55 mg/kg                        21 days
  2006               Journal of Health Sciences                                  Rats      55 mg/kg                        30 days
  2006               Molecular and Cellular Biochemistry                         Rats      100 mg/kg                       45 days
  2006               Basic & Clinical Pharmacology & Toxicology                  Rats      50 mg/kg                        45 days
  2006               Clinical and Experimental Pharmacology and Physiology       Rats      55 mg/kg                        30 days
  2006               Diabetes                                                    Mice      90-100 mg/kg                    3 weeks
  2006               Phytotherapy Research                                       Rats      50 mg/kg                        21 weeks
  2007               International Journal of Biological Macromolecules          Rats      50 mg/kg                        30 days
  2007               Journal of Ethnopharmacology                                Rats      55 mg/kg                        21 days
  2008               Experimental Diabetes Research                              Rats      45 mg/kg                        8 weeks
  2008               BMC Molecular Biology                                       Rats      65 mg/kg                        15 days
  2008               Atherosclerosis                                             Rats      60 mg/kg                        7 weeks
  2009               Clinical and Experimental Ophthalmology                     Rats      60 mg/kg                        1 week
  2010               Phytomedicine                                               Rats      60 mg/kg                        6 weeks
  2010               Pharmacognosy Res.                                          Rats      55 mg/kg                        15 days
  2010               Archives of Medical Research                                Rats      60 mg/kg                        32 weeks
  2011               Chemico-Biological Interactions                             Rats      50 mg/kg                        7 days
  2012               International Journal of Endocrinology                      Rats      65 mg/kg                        5 days
  2012               The Journal of Pharmacology And Experımental Therapeutıcs   Rats      60 mg/kg                        24 weeks
  2012               *West Virginia University, School of Medicine*              Mice      50 mg/kg                        5 weeks
  2012               Turkish Journal of Medical Sciences                         Rats      45 mg/kg                        8 weeks
  2013               BMC Complementary and Alternative Medicine                  Rats      55 mg/kg                        3 days
  2013               Diabetology & Metabolic Syndrome                            Rats      50 mg/kg                        60 days
  2014               BMC Pharmacology and Toxicology                             Rats      50 mg/kg                        1 week
  2014               Acta Histochemica                                           Rats      40 mg/kg                        72 hours
  2014               European Journal of Pharmacology                            Rats      50 mg/kg                        1 week
  2014               Phytomedicine                                               Rats      40 mg/kg                        4 weeks
  2014               Pain Medicine                                               Rats      30 mg/kg                        2 weeks
  2014               Pain Medicine                                               Rats      35 mg/kg                        2 weeks
  2014               Pain Medicine                                               Rats      40 mg/kg                        2 weeks
  2014               Food and Chemical Toxicology                                Rats      40 mg/kg                        28 days
  2015               International Journal of Experimental Pathology             Rats      45 mg/kg                        24 hours
  2015               Pharmacognosy Research                                      Rats      90 mg/kg                        10 weeks
  2015               Nutrition                                                   Rats      35 mg/kg                        72 hours
  2015               Renal Failure                                               Rats      60 mg/kg                        5 weeks

###### 

Descriptive Values regarding Plasma Insulin Levels, Unit of Plasma Insulin Levels and Individual Effect Sizes of the Differences in the Publications

  Publication Date   Name of Journal or Institution                              Plasma Insulin Level in Control Group   Plasma Insulin Level in STZ-induced Diabetic Group   Unit of Plasma Insulin Level   Effect Size
  ------------------ ----------------------------------------------------------- --------------------------------------- ---------------------------------------------------- ------------------------------ -------------
  2005               Biochemical and Biophysical Research Communications         3.11 ± 0.67                             0.34 ± 0.11                                          ng/ml                          5.8
  2005               Pharmacological Research                                    57 ± 5                                  58 ± 4                                               mU/L                           0.2 (-)
  2005               Journal of Ethnopharmacology                                35.40 ± 2.17                            6.75 ± 0.15                                          μU/mL                          18.7
  2005               Journal of Biochemistry and Molecular Biology               3.2 ± 0.4                               0.32 ± 0.1                                           ng/ml                          10.2
  2006               Clinical and Experimental Pharmacology and Physiology       15.86 ± 1.38                            5.12 ± 0.68                                          μU/mL                          9.9
  2006               Journal of Health Sciences                                  16.54 ± 1.07                            5.27 ± 0.76                                          μU/mL                          12.2
  2006               Molecular and Cellular Biochemistry                         13.67 ± 1.04                            6.89 ± 0.22                                          μU/mL                          9.1
  2006               Basic & Clinical Pharmacology & Toxicology                  13.67± 1.04                             6.89± 0.22                                           μU/mL                          9.1
  2006               Clinical and Experimental Pharmacology and Physiology       16.6 ± 2.1                              4.3 ± 1.3                                            μU/mL                          7.1
  2006               Diabetes                                                    0.90 ± 0.09                             0.58 ± 0.09                                          ng/ml                          3.5
  2006               Phytotherapy Research                                       2.49 ± 0.26                             0.44 ± 0.0                                           ng/ml                          14.6
  2007               International Journal of Biological Macromolecules          13.88 ± 14.52                           4.87 ± 0.53                                          μU/mL                          0.8
  2007               Journal of Ethnopharmacology                                296.21 ± 50.40                          69.89 ± 10.12                                        pM/L                           6.2
  2008               Experimental Diabetes Research                              11.8 ± 2.93                             3.97 ± 0.86                                          mIU/L                          3.64
  2008               BMC Molecular Biology                                       1.6 ± 0.3                               0.7 ± 0.3                                            ng/ml                          3
  2008               Atherosclerosis                                             1.82 ± 0.36                             0.05 ± 0.03                                          μg/L                           7.3
  2009               Clinical and Experimental Ophthalmology                     2.23±0.18                               0.99±0.31                                            ng/ml                          4.96
  2010               Phytomedicine                                               38.6±3.8                                8.2±1.4                                              μmol/mL                        10.6
  2010               Pharmacognosy Res.                                          390.87 ± 1.18                           420.25 ± 2.8                                         mg/dl                          13.7 (-)
  2010               Archives of Medical Research                                0.67±0.10                               0.18 ±0.01                                           ng/ml                          7
  2011               Chemico-Biological Interactions                             16.55 ± 1.17                            6.07 ± 0.99                                          μU/mL                          9.7
  2012               International Journal of Endocrinology                      38 ± 6                                  16 ± 2                                               μU/mL                          4.9
  2012               The Journal of Pharmacology And Experımental Therapeutıcs   1.69 ± 0.09                             0.29 ± 0.03                                          ng/dl                          23
  2012               *West Virginia University, School of Medicine*              1.92±0.17                               0.47±0.06                                            ng/ml                          6.1
  2012               Turkish Journal of Medical Sciences                         4.28 ± 0.83                             0.12 ± 0.02                                          ng/ml                          7.1
  2013               BMC Complementary and Alternative Medicine                  14.2 ± 0.583                            3.6 ± 0.509                                          μU/mL                          19.6
  2013               Diabetology & Metabolic Syndrome                            4.68± 0.84                              0.65 ±0.14                                           μU/mL                          6.7
  2014               BMC Pharmacology and Toxicology                             0.31 ± 0.05                             0.17 ± 0.04                                          ng/ml                          2.8
  2014               Acta Histochemica                                           15.41 ± 1.21                            8.37 ± 1.01                                          μU/mL                          6.3
  2014               European Journal of Pharmacology                            16.25±1.85                              5.02±0.43                                            μU/mL                          8.3
  2014               Phytomedicine                                               15.6 ± 0.5                              6.3 ± 0.26                                           μIU/mL                         23.8
  2014               Pain Medicine                                               4.26 ± 0.59                             2.28 ± 0.32                                          μU/mL                          4.3
  2014               Pain Medicine                                               4.26 ± 0.59                             2.20 ± 0.30                                          μU/mL                          4.5
  2014               Pain Medicine                                               4.26 ± 0.59                             2.04 ± 0.42                                          μU/mL                          4.4
  2014               Food and Chemical Toxicology                                15.9 ± 1.3                              26.1 ± 1.4                                           μU/mL                          7.5 (-)
  2015               International Journal of Experimental Pathology             6.18± 0.01                              0.95 ±0.12                                           ng/ml                          65.3
  2015               Pharmacognosy Research                                      17.66± 2.91                             83.33± 6.33                                          μU/mL                          13.3 (-)
  2015               Nutrition                                                   53.42±3.73                              41.64±2.91                                           μU/mL                          3.5
  2015               Renal Failure                                               8.40 ± 0.34                             2.50 ± 0.38                                          ng/ml                          16.8

###### 

Titles of the publications

  Publication Date   Titles of the publications
  ------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  2005               Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis
  2005               Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and -cell damage in rat pancreas
  2005               Study of the hypoglycaemic activity of Lepidium sativum L. aqueous extract in normal and diabetic rats
  2005               Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats
  2006               Beneficial effects of Aloe vera leaf gel extract on lıpıd profıle status in rats wıth streptozotocın diabetes
  2006               Anti-diabetic activity of fruits of terminalia chebula on streptozotocin induced diabetic rats
  2006               Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues
  2006               Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats
  2006               Biochemical evaluation of antidiabetogenic properties of some commonly used Indian plants on streptozotocin-induced diabetes in experimental rats
  2006               Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic -cell mass and function in a rodent model of type 2 diabetes
  2006               Effect of Japanese radish (Raphanus sativus) sprout (Kaiware-daikon) on carbohydrate and lipid metabolisms in normal and streptozotocin-induced diabetic rats
  2007               Protective effect of Lycium barbarum polysaccharides on streptozotocin-induced oxidative stress in rats
  2007               Effect of Sclerocarya birrea (Anacardiaceae) stem bark methylene chloride/methanol extract on streptozotocin-diabetic rats
  2008               The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model
  2008               Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats
  2008               Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus
  2009               Effect of N-acetylcysteine on the early expression of inflammatory markers in the retina and plasma of diabetic rats
  2010               Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats
  2010               Antihyperglycemic activity of *Catharanthus roseus* leaf powder in streptozotocin-induced diabetic rats
  2010               Effect of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor (Vildagliptin) on Peripheral Nerves in Streptozotocin-induced Diabetic Rats
  2011               Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats
  2012               Intermittent Fasting Modulation of the Diabetic Syndrome in Streptozotocin-Injected Rats
  2012               Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
  2012               Examination of novel cardiac mechanisms ınfluencing mitochondrial proteomes during diabetes mellitus
  2012               Effects of lycopene on plasma glucose, insulin levels, oxidative stress, and body weights of streptozotocin-induced diabetic rats
  2013               Anti-diabetic, anti-oxidant and anti-hyperlipidemic activities of Melastoma malabathricum Linn. leaves in streptozotocin induced diabetic rats
  2013               The effect of a novel curcumin derivative on pancreatic islet regeneration in experimental type-1 diabetes in rats (long term study)
  2014               CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients
  2014               β-Caryophyllene, a natural sesquiterpene, modulates carbohydrate metabolism in streptozotocin-induced diabetic rats
  2014               Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats
  2014               Efficacy of natural diosgenin on cardiovascular risk, insulin secretion, and beta cells in streptozotocin (STZ)-induced diabetic rats
  2014               Establishment of a Rat Model of Type II Diabetic Neuropathic Pain
  2014               Polyphenols-rich Cyamopsis tetragonoloba (L.) Taub. beans show hypoglycemic and β-cells protective effects in type 2 diabetic rats
  2015               Effect of strawberry (Fragaria 3 ananassa) leaves extract on diabetic nephropathy in rats
  2015               Anti-diabetic effects of ethanol extract of *Bryonia laciniosa* seeds and its saponins rich fraction in neonatally streptozotocin-induced diabetic rats
  2015               Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress, as well as inhibiting NF-kB activation and iNOS expression in rat pancreas
  2015               The effects of transdermal insulin treatment of streptozotocin-induced diabetic rats on kidney function and renal expression of glucose transporters

Calculation of Effect Sizes and Analysis {#sec2-2}
----------------------------------------

In this study plasma insulin levels measured in control and STZ groups were considered for calculating effect size values. The effect size of differences regarding plasma insulin levels were accepted as an indicator of practical importance of the differences, therefore one Cohen d formula was used to calculate effect sizes \[[@ref21], [@ref22]\].

d= M~1~-M~2~ /√\[σ~1~^2^~+~ σ~2~^2^/2\] for independent measures

After individual effect sizes per difference in each publication were calculated, mean effect size value was obtained by adding all effect sizes and dividing total effect size score into number of individual effect sizes. Hence just only one value regarding effect of STZ on plasma insulin levels was gathered.

Results {#sec1-3}
=======

Results of the study showed that only 4 of the all individual effect sizes indicated negative values while the rest of effect sizes (n=35) was positive. Moreover one small and 38 large effect sizes were seen in the calculations. Descriptive values regarding Plasma Insulin Levels in control and STZ-induced diabetes groups, Unit of Plasma Insulin Levels and Individual Effect Sizes were shown in [Table 2](#T2){ref-type="table"}.

As seen in the [Table 2](#T2){ref-type="table"}, the individual effect sizes were between -13.7 to +65.3. The mean effect size value was found as +9.33.

Discussion {#sec1-4}
==========

The results of this study made it clearer that STZ-application is an effective way of decreasing significantly plasma insulin levels of rats and mice. Mean effect size value calculated from the publications showed that practical importance of STZ-induced decrease in plasma insulin levels had a large effect. In other words effect size value of +9.33 refers to a large effect size \[[@ref23]\]. Therefore the mean value of the STZ applied group is over 90 percentile of the no treatment group or control group.

The results of the study are in line with the findings of the current research studies using STZ for inducing diabetes in rats and mice \[[@ref9], [@ref10]\]. Sai Varsha, Thiagarajan, Manikandan and Dhanasekaran applied STZ (35mg/kg) to Male albino Wistar rats, the authors observed plasma insulin decrease in rats after 72 hours \[[@ref24]\].

The findings of this study contribute to our understandings about practical importance of differences in plasma insulin levels induced by STZ. When looked at the number of the publications in this study, it can be seen that decisions are based on differences in the publications over 35. Hence the findings of this study make our inferences about plasma insulin level differences induced by STZ more valid rather than relying on only one study's finding. At the same time findings of the study has a potential for informing researchers about dose and duration of STZ application to change plasma insulin levels of diabetic rats and mice. As another implication of this study, the publications analyzed in this study show characteristics of current practice about using STZ, therefore the effect sizes reported in this study also inform practice using STZ in diabetes studies.

In spite of strong sides of this study, it can be suggested that number of the publications using STZ might be increased in future studies to improving quality of inferences and to make the analysis more comprehensive. At the same time, other publications involving reports and unpublished documents should also be investigated for determining effect sizes regarding the differences about plasma insulin levels induced by STZ. Finally future studies might look at the studies published before 2005.
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